Most clinicians think of radiotherapy in the context of cancer treatment. Although superficial radiation therapy is often used to treat skin cancer, there are many benign conditions where this treatment modality provides excellent clinical outcomes and a positive patient experience. In this webinar, Dr. Richard Shaffer, clinical oncologist with Genesis Care, shares his experience using radiotherapy as a non-invasive alternative to other treatments for patients who suffer from Dupuytrens disease and Ledderhose disease. Dr. Shaffer will highlight a few recent cases showing why he chose radiotherapy and the clinical outcomes his patients experienced.
XBeam from Xstrahl Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance for Use in the U.S.
Xstrahl’s XBeam has received FDA 510(k) Clearance for Use in the U.S. The XBeam technology streamlines radiotherapy treatment planning and simplifies patient workflow for treating skin cancer, benign diseases, and palliative care. Explore how this innovation enhances orthovoltage superficial radiotherapy (SRT) and electronic brachytherapy (eBt). With XBeam, you can calculate, protocol and export treatment plans for Xstrahl treatments with Radiant Aura and all other Xstrahl medical devices in the U.S. and worldwide.
